ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991

CCOP Recompetition Approved By NCAB

May 23, 1986

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013